Diabetes, Labelling and People Management

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Diabetes

Labelling

People Management

Blood Sugar, Hashimoto’s, Ozempic, Metformin and Berberine

The Thyroid Pharmacist

NOVEMBER 15, 2024

There is a known link between Hashimoto’s and type 2 diabetes, with up to 30 percent of those with Hashimoto’s developing the condition. Conversely, patients with type 2 diabetes are at an increased risk of developing a thyroid disorder, especially women. Ozempic is a recent blockbuster drug with benefits for diabetes and weight.

Diabetes

Diabetes Immunization Immunity Compounding

FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction

Pharmaceutical Business Review

MARCH 11, 2024

This label expansion follows a supplemental New Drug Application (sNDA) submitted by the company. Participants in the trial, all of whom were aged 45 years or above with a body mass index (BMI) of 27 kg/m2 or higher and without a history of diabetes, were observed over a five-year period.

Labelling

Labelling People Management Diabetes

Pharmacist Digest

Blood Sugar, Hashimoto’s, Ozempic, Metformin and Berberine

FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction

Stay Connected